V-Bio Ventures, an independent venture capital firm specialized in developing and financing young, innovative life sciences companies, has announced the final close of its second fund, V-Bio Fund 2, having raised €110m (US$120.6m), exceeding its target of €100m. The close brings the total raised at V-Bio, along with V-Bio Fund 1, to over €185m. Almost…